OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Response rates to sequential trials of antipsychotic medications according to algorithms or treatment guidelines in psychotic disorders. A systematic review and meta-analysis
Brian O’Donoghue, Francesco Piacenza, Helena Plapp, et al.
Schizophrenia Research (2024) Vol. 268, pp. 193-204
Open Access | Times Cited: 7
Brian O’Donoghue, Francesco Piacenza, Helena Plapp, et al.
Schizophrenia Research (2024) Vol. 268, pp. 193-204
Open Access | Times Cited: 7
Showing 7 citing articles:
Comparative effectiveness of antipsychotic treatment strategies for relapse prevention in first-episode schizophrenia in Finland: a population-based cohort study
Heidi Taipale, Antti O. Tanskanen, Oliver Howes, et al.
The Lancet Psychiatry (2025) Vol. 12, Iss. 2, pp. 122-130
Open Access | Times Cited: 1
Heidi Taipale, Antti O. Tanskanen, Oliver Howes, et al.
The Lancet Psychiatry (2025) Vol. 12, Iss. 2, pp. 122-130
Open Access | Times Cited: 1
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Promoting safer and wider worldwide use of clozapine
José de León
Schizophrenia Research (2024)
Closed Access | Times Cited: 3
José de León
Schizophrenia Research (2024)
Closed Access | Times Cited: 3
Clozapine may consistently protect from suicidal behaviors while other antipsychotics may lack a specific protective effect: a comprehensive VigiBase study interpreted in the context of the prior literature
Carlos De las Cuevas, Victoria de León-Martínez, Hilario Blasco‐Fontecilla, et al.
Expert Opinion on Drug Safety (2024), pp. 1-11
Closed Access | Times Cited: 3
Carlos De las Cuevas, Victoria de León-Martínez, Hilario Blasco‐Fontecilla, et al.
Expert Opinion on Drug Safety (2024), pp. 1-11
Closed Access | Times Cited: 3
Identifying and managing treatment resistance early with the integration of a clozapine clinic within an early intervention for psychosis service
Brian O’Donoghue, Linda Mora, Marie Bismark, et al.
Early Intervention in Psychiatry (2024)
Closed Access | Times Cited: 1
Brian O’Donoghue, Linda Mora, Marie Bismark, et al.
Early Intervention in Psychiatry (2024)
Closed Access | Times Cited: 1
Evaluating the adverse drug reactions to clozapine in populations of children and adolescents: insights from VigiBase data
Carlos De las Cuevas, Emílio J. Sanz, Sara Jiménez‐Fernández, et al.
European Child & Adolescent Psychiatry (2024)
Closed Access | Times Cited: 1
Carlos De las Cuevas, Emílio J. Sanz, Sara Jiménez‐Fernández, et al.
European Child & Adolescent Psychiatry (2024)
Closed Access | Times Cited: 1
Response to clozapine and its predictors in treatment-resistant schizophrenia spectrum disorders: A retrospective chart review
Rajkumar Sanahan, Vanteemar S. Sreeraj, Satish Suhas, et al.
Schizophrenia Research (2024) Vol. 275, pp. 179-188
Closed Access
Rajkumar Sanahan, Vanteemar S. Sreeraj, Satish Suhas, et al.
Schizophrenia Research (2024) Vol. 275, pp. 179-188
Closed Access
A Case of Clozapine-Induced Hepatotoxicity: Management Considerations and Future Direction
Matthew B Bulkley, Kendahl Oberdorfer, Renee R Maan
Cureus (2024)
Open Access
Matthew B Bulkley, Kendahl Oberdorfer, Renee R Maan
Cureus (2024)
Open Access
